Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports.Check Now!

Home
report store
genital warts epidemiology forecast

SALE

Genital Warts (Condyloma Acuminatum)- Epidemiology Forecast–2034

Published Date : 2025

Pages : 83

Region : United States, Japan, China, EU4 & UK

SALE

Summary
TOC Table of Content
LOT
- Sample Request

Genital Warts Market

DelveInsight’s "Genital Warts (Condyloma Acuminatum)- Epidemiology Forecast–2034" report delivers an in-depth understanding of the Genital Warts (Condyloma Acuminatum), historical and forecasted epidemiology as well as the Genital Warts (Condyloma Acuminatum) trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan, and China.

Geographies Covered

The United States
EU5 (Germany, France, Italy, Spain, and the United Kingdom)
Japan
China

Study Period: 2021-2034

Genital Warts Disease Understanding

Genital warts (also known as anogenital warts, condylomata acuminata, condylomas) are benign proliferative lesions caused by human papillomavirus (HPV) types 6 and 11, which are found in >95% of lesions. Genital warts (GWs) are transmitted by having sexual contact with someone who already has them and may be found on the outside of genitals. Some types, which cause cancer, result in the growth of lesions on a woman's cervix. It is possible to get genital warts, HPV infection, even if they are not visible. Besides, they look like flesh-colored bumps that have a cauliflower-like appearance, and are usually flat, papular, or pedunculated growths on the genital mucosa, occurring in clusters.

GWs can appear on the penis, vulva, vagina, cervix, groin, or thigh within weeks or months after sexual contact with an infected person. Potentially cancer-causing HPV strains are spread by sexual intercourse, anal sex, and oral sex.

Genital Warts Diagnosis

Genital warts are often diagnosed by appearance. Sometimes a biopsy might be necessary based on indications such as atypical appearance, HIV positive persons, pigmented warts, poor response to the treatment and unclear diagnosis. Clinical diagnosis of GW is based on the appearance of warts, whereas histopathological diagnosis is not routinely indicated. Nucleic Acid Amplification Test for HPV DNA is also recommended. Accurate diagnosis is an essential first step in the treatment of GWs. They can be flat, dome-shaped, keratotic, pedunculated, and cauliflower-shaped; they may occur singularly, in clusters, or as plaques. Understanding the morphological presentation of these lesions is essential to accurate diagnosis of EGWs and their differentiation from other lesions that mimic them. However, warts are not exclusive to external genital tissues. Sexual exposure can be associated with warts in the urethra and at the meatus, cervix, vagina, anus, and oral cavity. Cervical warts, however, require clinicians to rule out high-grade dysplasia using Papanicolaou (Pap) tests before treatment.

Continued in the report…..

Genital Warts Epidemiology Perspective by DelveInsight

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Incident cases of Genital Warts, Gender-specific Incident Cases of Genital Warts, Age-specific Incident Cases of Genital Warts, Anatomical Location of Genital Warts in Incident Population in the 7MM+China covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), Japan, and China from 2021 to 2034.

Genital Warts Detailed Epidemiology Segmentation

In the assessment done by DelveInsight, the estimated total incident cases of GWs in the 7MM+China were 1,392,836 in 2021.
The highest incident cases of GWs were accounted by the US in 2021 (545,316 cases), which are expected to show a rise in the future.
Among the European countries, Germany had the highest incident population of GWs with 77,210 cases, followed by France, which had incident population of 55,798 in 2021. On the other hand, Spain had the lowest incident population (42,588 cases).
Japan had 38,043 incident cases for GWs in 2021, accounting for approximately 3% in 7MM+China.

Scope of the Report

The report covers the descriptive overview of Genital Warts, explaining its symptoms, grading, pathophysiology, and various diagnostic approaches.
The report provides insight into the 7MM+China historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), Japan, and China.
The report assesses the disease risk and burden of Genital Warts.
The report helps to recognize the growth opportunities in the 7MM+China with respect to the patient population.

Explore the key factors, trends, innovations, and developments driving the market growth, at: Genital Warts (Condyloma Acuminatum) Market

Report Highlights

10-year forecast of Genital Warts
7MM+China Coverage
Incident Cases of Genital Warts
Gender-specific Incident Cases of Genital Warts
Age-specific Incident Cases of Genital Warts
Anatomical Location of Genital Warts in Incident Population

Key Questions Answered

What are the disease risk and burden of Genital Warts?
What is the historical Genital Warts patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK), Japan and China?
What would be the forecasted patient pool of Genital Warts at the 7MM+China level?
What will be the growth opportunities across the 7MM+China with respect to the patient population pertaining to Genital Warts?
Out of the above-mentioned countries, which country would have the highest incident population of Genital Warts during the forecast period (2025-2034)?
At what CAGR the population is expected to grow across the 7MM+China during the forecast period (2025-2034)?

Reasons to buy

The Genital Warts report will allow the user to -

Develop business strategies by understanding the trends shaping and driving the 7MM+China Genital Warts epidemiology forecast.
The Genital Warts epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
The Genital Warts epidemiology model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the 10-year forecast period using reputable sources.

Key Assessments

Patient Segmentation
Patient Segmentation based on Gender
Patient Segmentation based on Age
Patient Segmentation based on Anatomical Location of Genital Warts

1. Key Insights

2. Report Introduction

3. Genital Warts Epidemiology Overview at a Glance

3.1. Patient Share (%) Distribution of Genital Warts by Countries in 2021

3.2. Patient Share (%) Distribution of Genital Warts by Countries in 2034

4. Genital Warts Epidemiology: Future Perspective

5. Executive Summary of Genital Warts

6. Disease Background and Overview: Genital Warts

6.1. Introduction

6.2. Natural History

6.3. Causes and Risks

6.4. Symptoms

6.5. Pathophysiology

6.6. Clinical Presentation

6.7. Complications of Untreated HVP Infection

6.8. Diagnosis

6.8.1. Pap Test

6.8.2. HPV test

6.8.3. Newer Techniques

6.8.4. Diagnostic Guidelines

7. Treatment and Management

7.1. Chemical Treatment (Self-administered)

7.2. Chemical Treatment (Physician-applied)

7.3. Other Treatments

7.4. Ablative Treatment

7.5. Preventive Treatment

7.6. Therapies Not Recommended

7.6.1. Enhancing the Efficacy of Imiquimod

7.7. Adverse Effects of Treatment

7.8. Selection of Treatment

7.9. Special Management Issues

8. Vaccines

8.1. Gardasil: Merck

8.2. Cervarix: GlaxoSmithKline

8.3. Comparison

8.4. Differences

9. Guidelines

9.1. Anogenital Warts Treatment Guidelines: CDC

9.2. European Guideline for the Management of Anogenital Warts

9.3. Guidance on HPV vaccination in EU countries: Focus on boys, people living with HIV, and 9-valent HPV vaccine introduction: ECDC

9.4. Guidelines for the Management of Anogenital Warts in China

10. Epidemiology and Patient Population

10.1. Key Findings

10.2. Methodology of Epidemiology

10.3. Assumptions and Rationale: 7MM+China

10.3.1. United States

10.3.2. EU5 Countries

10.3.3. Japan

10.3.4. China

10.4. Total Incidence of GWs in the 7MM+China

10.5. The United States

10.5.1. Incident Cases of GWs in the United States

10.5.2. Gender Specific Incident Cases of GWs in the United States

10.5.3. Age Specific Incident Cases of GWs in the United States

10.5.4. Anatomical Location of GWs in Incident Population in the United States

10.6. Major Five European Countries

10.6.1. Incident cases of GWs in the EU-5

10.6.2. Gender Specific Incident Cases of GWs in the EU-5

10.6.3. Age Specific Incident Cases of GWs in the EU5

10.6.4. Anatomical Location of GWs in Incident Population in the EU-5

10.7. Japan

10.7.1. Incidence Cases of GWs in Japan

10.7.2. Gender Specific Incident Cases of GWs in Japan

10.7.3. Age Specific Incident Cases of GWs in Japan

10.7.4. Anatomical Location of GWs in Incidence Population in Japan

10.8. China

10.8.1. Incidence Cases of GWs in China

10.8.2. Gender Specific Incident Cases of GWs in China

10.8.3. Age Specific Incident Cases of GWs in China

10.8.4. Anatomical Location of GWs in Incident Population in China

11. Patient Journey

12. Appendix

12.1. Bibliography

12.2. List of Abbreviations

12.3. Report Methodology

13. DelveInsight Capabilities

14. Disclaimer

15. About DelveInsight

List of Tables:

List of Table

Table 1: Summary of Genital Warts Epidemiology (2021-2034)

Table 2: Low-risk HPV versus High-risk HPV

Table 3: Treatment Modalities

Table 4: Treatments and their Advantages

Table 5: Enhancing the efficacy of imiquimod

Table 6: Gardasil versus Cervarix

Table 7: Total Incident Population of GWs in 7MM+China (2021-2034)

Table 8: Incident cases of GWs in the United States (2021-2034)

Table 9: Gender Specific Diagnosed Cases of GWs in the United States (2021-2034)

Table 10: Age Specific Diagnosed Cases of GWs in the United States (2021-2034)

Table 11: Anatomical Location of GWs in Incident Population in the United States (2021-2034)

Table 12: Incident Cases of GWs in the EU-5 (2021-2034)

Table 13: Gender Specific Incident Cases of GWs in the EU-5 (2021-2034)

Table 14: Age Specific Incident Cases of GWs in the EU-5 (2021-2034)

Table 15: Age Specific Incident of GWs in Incident Population in the EU-5 (2021-2034)

Table 16: Incident Cases of GWs in Japan (2021-2034)

Table 17: Gender Specific Incident Cases of GWs in Japan (2021-2034)

Table 18: Age Specific Incident Cases of GWs in Japan (2021-2034)

Table 19: Anatomical Location of GWs in Incident Population in Japan (2021-2034)

Table 20: Incident Cases of GWs in China (2021-2034)

Table 21: Gender Specific Incident Cases of GWs in China (2021-2034)

Table 22: Age Specific Incident Cases of GWs in China (2021-2034)

Table 23: Anatomical Location of GWs in Incident Population in China (2021-2034)

Table 24: List of abbreviations

List of Figures:

List of Figures

Figure 1: Different Types of Warts

Figure 2: HPV Structure and Function

Figure 3: HPV Structure and Function

Figure 4: Infection by HPV

Figure 5: Checklist for Initial Consultation

Figure 6: Checklist for providing Treatment

Figure 7: Treatment Algorithm

Figure 8: Newer Simplified Treatment Algorithm

Figure 9: Algorithm for Treatment Selection

Figure 10: Algorithm for Treatment Selection in Pregnant Patients

Figure 11: Total Incident Population of GWs in 7MM+China (2021-2034)

Figure 12: Incident cases of GWs in the United States (2021-2034)

Figure 13: Gender Specific Incident Cases of GWs in the United States (2021-2034)

Figure 14: Age Specific Incident Cases of GWs in the United States (2021-2034)

Figure 15: Anatomical Location of GWs in Incident Population in the United States (2021-2034)

Figure 16: Incident Cases of GWs in the EU-5 (2021-2034)

Figure 17: Gender Specific Incident Cases of GWs in the EU-5 (2021-2034)

Figure 18: Age Specific Incident Cases of GWs in the EU5 (2021-2034)

Figure 19: Anatomical Location of GWs in Incident Population in the EU5 (2021-2034)

Figure 20: Incident Cases of GWs in Japan (2021-2034)

Figure 21: Gender Specific Incident Cases of GWs in Japan (2021-2034)

Figure 22: Age Specific Incident Cases of GWs in Japan (2021-2034)

Figure 23: Anatomical Location of GWs in Incidence Population in Japan (2021-2034)

Figure 24: Incidence Cases of GWs in China (2021-2034)

Figure 25: Gender Specific Incident Cases of GWs in China (2021-2034)

Figure 26: Age Specific Incident Cases of GWs in China (2021-2034)

Figure 27: Anatomical Location of GWs in Incident Population in China (2021-2034)

Figure 28: Patient Journey

Tags:

License Type

Offer